Incannex Healthcare Ltd ADR

Here is the public summary page for Incannex Healthcare Ltd ADR. Please login to see the complete information for Incannex Healthcare Ltd ADR including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Incannex Healthcare Ltd ADR stacks up relative to its peers.


Darwin Score-19
TickerIXHL
Latest Price1.05 USD as of close on 25-Jul-2025
3 Month price range0.09 to 1.63 USD
Market Capitalisation152.72Mn USD
CountryUnited States of America
RegionNorth America
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryBiotechnology
Sub-IndustryBiotechnology
Description
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that has completed Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate in Phase 2 clinical trial to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia.
See More ...
Company URLhttps://www.incannex.com
See Darwins Full Analysis for Incannex Healthcare Ltd ADR

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Incannex Healthcare Ltd ADR. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages+10
SentimentNews and Candle Patterns. -1
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.-5
FlowInstitutional, Fund and Insider buying and selling.-2
ModelsForecast models.-21

Alerts

There are 20 live alerts for Incannex Healthcare Ltd ADR.


Peer Comparison

There are 27 peers of Incannex Healthcare Ltd ADR.
Asset NameIndustry GroupPerf(20d)%Asset Score
ACADIA Pharmaceuticals Inc (ACAD)Biotechnology+4.7+9
Abivax SA American Depositary Shares (ABVX)Biotechnology+826.0+31
Amgen Inc (AMGN)Biotechnology+9.8+22
Arrowhead Pharmaceuticals Inc (ARWR)Biotechnology-2.1-24
BioMarin Pharmaceutical Inc (BMRN)Biotechnology+9.1-19
Biogen Inc (BIIB)Biotechnology+3.6-13
Black Diamond Therapeutics Inc (BDTX)Biotechnology+20.7+1
Cyclacel Pharmaceuticals Inc (CYCC)Biotechnology+205.7-26
Dynavax Technologies Corp (DVAX)Biotechnology+14.3+2
Exelixis Inc (EXEL)Biotechnology+5.8+30
FibroGen Inc (FGEN)Biotechnology+40.6-14
Gilead Sciences Inc (GILD)Biotechnology+8.0+19
Halozyme Therapeutics Inc (HALO)Biotechnology+10.9+8
Humacyte Inc (HUMA)Biotechnology+14.0+1
Incyte Corp (INCY)Biotechnology-0.9-2
Krystal Biotech Inc (KRYS)Biotechnology+3.5-5
MacroGenics Inc (MGNX)Biotechnology+34.6+1
Moderna Inc (MRNA)Biotechnology+24.0+14
Myriad Genetics Inc (MYGN)Biotechnology-16.5-14
Neurocrine Biosciences Inc (NBIX)Biotechnology+4.3+21
NuCana PLC (NCNA)Biotechnology-27.8-16
OPKO Health Inc (OPK)Biotechnology+3.8-6
Regeneron Pharmaceuticals Inc (REGN)Biotechnology+8.1+2
Replimune Group Inc (REPL)Biotechnology-66.7-19
United Therapeutics Corp (UTHR)Biotechnology+7.2-2
Vertex Pharmaceuticals Inc (VRTX)Biotechnology+5.9+20
Vir Biotechnology Inc (VIR)Biotechnology+6.4-16

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn